Q1 2023 Holdings
Filed 2023-05-15 | 76 holdings | $2.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $203.5M | 18,346,861 | 8.8% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $153.2M | 1,913,280 | 6.6% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $102.3M | 4,205,206 | 4.4% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $86.2M | 5,582,105 | 3.7% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $78.2M | 2,044,389 | 3.4% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $77.8M | 2,925,648 | 3.4% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $73.9M | 12,957,222 | 3.2% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $71.4M | 2,410,769 | 3.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $67.6M | 1,879,739 | 2.9% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $67.3M | 3,811,988 | 2.9% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $54.9M | 6,067,918 | 2.4% |
| Penumbra Inc(PEN) | COM | 70975L107 | $52.4M | 187,992 | 2.3% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $51.7M | 1,186,418 | 2.2% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $49.4M | 1,612,094 | 2.1% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $49.0M | 335,159 | 2.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $48.6M | 130,540 | 2.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $47.5M | 1,325,832 | 2.1% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $45.8M | 3,334,355 | 2.0% |
| OAK STR Health Inc(OSH3EUR) | COM | 67181A107 | $41.1M | 1,061,295 | 1.8% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $40.1M | 610,304 | 1.7% |
| Dexcom Inc(DXCM) | COM | 252131107 | $39.0M | 336,048 | 1.7% |
| Stryker Corporation(SYK) | COM | 863667101 | $39.0M | 136,464 | 1.7% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $34.5M | 4,145,396 | 1.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $32.6M | 335,170 | 1.4% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $31.9M | 231,595 | 1.4% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $31.2M | 449,442 | 1.4% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $31.0M | 1,640,725 | 1.3% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $30.9M | 8,046,217 | 1.3% |
| Elevance Health Inc(ELV) | COM | 036752103 | $30.5M | 66,398 | 1.3% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $27.3M | 815,774 | 1.2% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $26.6M | 1,831,608 | 1.2% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $26.5M | 13,565,249 | 1.1% |
| Humana Inc(HUM) | COM | 444859102 | $25.3M | 52,079 | 1.1% |
| Augmedix Inc(AUGX) | COM | 05105P107 | $25.0M | 14,380,327 | 1.1% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $25.0M | 3,124,226 | 1.1% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $24.9M | 2,533,050 | 1.1% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $24.5M | 1,992,843 | 1.1% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $24.4M | 2,749,384 | 1.1% |
| Stevanato Group S P A(STVN) | ORD SHS | T9224W109 | $23.4M | 901,932 | 1.0% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $23.3M | 115,328 | 1.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $20.4M | 1,317,031 | 0.9% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $19.3M | 6,926,926 | 0.8% |
| Centene Corp del(CNC) | COM | 15135B101 | $17.5M | 277,351 | 0.8% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $16.5M | 5,619,914 | 0.7% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $16.3M | 5,612,056 | 0.7% |
| Verve Therapeutics Inc | COM | 92539P101 | $16.2M | 1,120,679 | 0.7% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $14.3M | 71,657 | 0.6% |
| Absci Corporation(ABSI) | COM | 00091E109 | $14.1M | 8,031,094 | 0.6% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $13.7M | 900,000 | 0.6% |
| Annexon Inc(ANNX) | COM | 03589W102 | $13.5M | 3,503,190 | 0.6% |